Search PDMR transactions

Notifier
Name of person with notification obligation
Axel Schörling
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Axel Schörling
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
EQL Pharma
Issuer´s LEI code
549300Q8B2D2AE8GCW21
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share EQL Pharma SE0005497732 Acquisition 53,903 Quantity 47.05 SEK 24/05/2024 SPOTLIGHT STOCK MARKET
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
EQL Pharma SE0005497732 Acquisition 24/05/2024 SPOTLIGHT STOCK MARKET 53,903 (Quantity) 47.05 SEK
Total: 53,903
<< Back